Millions of Americans who need aggressive cholesterol lowering but dread regular injections now have a new option: a ...

For a decade, the most powerful non-statin cholesterol drugs have come with a catch: they had to be injected. That changed ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

Add Yahoo as a preferred source to see more of our stories on Google. Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that's previously only has ...

In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new ...

On July 16, 2026, the FDA approved the first pill version of this same idea: Lipfendra (enlicitide), a once-daily tablet for ...

Pittsburgh doctors on Thursday hailed government approval of a highly effective anti-cholesterol pill that had previously been available only as an injection, but they cautioned that cheap, ...

Doctors say the new drug could make treatment more accessible for patients by addressing two common concerns: convenience and ...

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections. The drug, called enlicitide, slashes levels ...

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.

The Food and Drug Administration approved a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only been available with injectable drugs. The drug from Merck was approved ...

Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only has been available with injectable drugs. The Food and Drug Administration ...